On February 21, 2017, a European Respiratory Society research seminar held in Barcelona
discussed how to best apply precision medicine to chronic airway diseases such as asthma …

Asthma and chronic obstructive pulmonary disease (COPD) are two prevalent chronic
airway diseases that have a high personal and social impact. They likely represent a …

The term “precision medicine” has become very popular over recent years, fuelled by
scientific as well as political perspectives. Despite its popularity, its exact meaning, and how …

In the majority of cases, asthma and chronic obstructive pulmonary disease (COPD) are two
clearly distinct disease entities. However, in some patients there may be significant overlap …

Asthma is a heterogeneous disease comprising several phenotypes driven by different
pathways. To define these phenotypes or endotypes (phenotypes defined by mechanisms) …

Although there has been tremendous growth in our understanding of chronic obstructive
pulmonary disease (COPD) and its pathophysiology over the past few decades, the pace of …

Chronic obstructive pulmonary disease (COPD) was the fourth leading cause of death
worldwide in 2015. Current treatments for patients ease discomfort and help decrease …

The treatable traits approach represents a strategy for patient management. It is based on
the identification of characteristics susceptible to treatments or predictive of treatment …

Chronic airway diseases such as asthma and chronic obstructive pulmonary disease are
prevalent and complex conditions that often coexist in the same patient. To address this …

Unbiased definition of phenotypes or endotypes (which are phenotypes defined by
mechanisms) is an important step towards the use of precision medicine in asthma …